Shu Wang

1.4k total citations
78 papers, 818 citations indexed

About

Shu Wang is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Shu Wang has authored 78 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Surgery, 21 papers in Pulmonary and Respiratory Medicine and 16 papers in Epidemiology. Recurrent topics in Shu Wang's work include Inflammatory Bowel Disease (7 papers), Kidney Stones and Urolithiasis Treatments (6 papers) and Pediatric Urology and Nephrology Studies (6 papers). Shu Wang is often cited by papers focused on Inflammatory Bowel Disease (7 papers), Kidney Stones and Urolithiasis Treatments (6 papers) and Pediatric Urology and Nephrology Studies (6 papers). Shu Wang collaborates with scholars based in China, United States and Greece. Shu Wang's co-authors include Kai‐Hsin Lin, Kuo‐Sin Lin, Jianxing Li, Yuzhe Tang, Mohummad Minhaj Siddiqui, Xin Zhang, Kewei Jiang, Hua Li, Bin Liang and Lizheng Qin and has published in prestigious journals such as Nature Communications, PLoS ONE and Diabetes.

In The Last Decade

Shu Wang

65 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu Wang China 17 245 237 202 121 98 78 818
Roy Lalisang Netherlands 18 232 0.9× 441 1.9× 255 1.3× 98 0.8× 80 0.8× 51 1.2k
Yoon Ji Choi South Korea 18 282 1.2× 170 0.7× 456 2.3× 155 1.3× 251 2.6× 111 1.1k
Abigail Doucette United States 16 427 1.7× 99 0.4× 322 1.6× 57 0.5× 122 1.2× 64 971
Karin A. Rosenblatt United States 21 133 0.5× 172 0.7× 296 1.5× 116 1.0× 102 1.0× 39 1.6k
Ailín C. Rogers Ireland 19 210 0.9× 549 2.3× 503 2.5× 47 0.4× 133 1.4× 47 1.2k
Jihoon Kim South Korea 18 259 1.1× 381 1.6× 177 0.9× 57 0.5× 97 1.0× 93 1.1k
John P. Cleary United States 19 377 1.5× 335 1.4× 130 0.6× 137 1.1× 280 2.9× 43 1.1k
Kyung Duk Park South Korea 20 185 0.8× 174 0.7× 199 1.0× 51 0.4× 209 2.1× 103 1.2k
Ching-Tien Peng Taiwan 20 163 0.7× 172 0.7× 101 0.5× 53 0.4× 173 1.8× 42 999
P. Dirschedl Germany 17 371 1.5× 459 1.9× 468 2.3× 174 1.4× 199 2.0× 47 1.5k

Countries citing papers authored by Shu Wang

Since Specialization
Citations

This map shows the geographic impact of Shu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Wang more than expected).

Fields of papers citing papers by Shu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Wang. The network helps show where Shu Wang may publish in the future.

Co-authorship network of co-authors of Shu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Wang. A scholar is included among the top collaborators of Shu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Wang. Shu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Jing, Kai Zhang, Shu Wang, et al.. (2025). Promotion of microplastic degradation on the conjugative transfer of antibiotic resistance genes in the gut of macrobenthic invertebrates. Ecotoxicology and Environmental Safety. 293. 117999–117999. 1 indexed citations
2.
Yuan, Bo, Xiaojuan Fan, Weike Li, et al.. (2025). Effective in vivo RNA base editing via engineered cytidine deaminase APOBECs fused with PUF proteins. Nature Communications. 16(1). 9727–9727.
3.
Ballman, Karla V., Ariel E. Marciscano, Christopher E. Barbieri, et al.. (2024). Radiation therapy and IRreversible electroporation for intermediate risk prostate cancer (RTIRE). BMC Urology. 24(1). 151–151. 2 indexed citations
4.
5.
Wang, Shu, Jinghong Dai, Xuemin Zhang, et al.. (2023). Establishment and Validation of Models for the Risk of Multi-Drug Resistant Bacteria Infection and Prognosis in Elderly Patients with Pulmonary Infection: A Multicenter Retrospective Study. Infection and Drug Resistance. Volume 16. 6549–6566. 2 indexed citations
7.
Wang, Shu, Teklu Legesse, Vikas Kundra, et al.. (2022). Prostate cancer grade downgrading at time of prostatectomy provides risk‐stratification insight into future tumor behavior after prostatectomy. The Prostate. 82(16). 1520–1528. 4 indexed citations
8.
Liu, Mengyao, et al.. (2022). Alteration of Peripheral Resistin and the Severity of Acute Pancreatitis: A Meta-Analysis. Frontiers in Medicine. 9. 915152–915152. 5 indexed citations
9.
Bressler, Brian, Andrés Yarur, Uri Kopylov, et al.. (2020). P419 Clinical effectiveness and safety of first-line biologic vedolizumab as a monotherapy or combination therapy in ulcerative colitis and Crohn’s disease patients: results from the EVOLVE study. Journal of Crohn s and Colitis. 14(Supplement_1). S381–S382. 1 indexed citations
10.
Shen, Shuwei, et al.. (2019). Emerging effect of anesthesia on post-operative tumor recurrence and metastasis. Journal of International Medical Research. 47(8). 3550–3558. 13 indexed citations
11.
12.
Wang, Shu, et al.. (2019). An evaluation of multidrug-resistant (MDR) bacteria in patients with urinary stone disease: data from a high-volume stone management center. World Journal of Urology. 38(2). 425–432. 16 indexed citations
13.
Gao, Zhidong, Kai Shen, Zhanlong Shen, et al.. (2017). Safety, quality and effect of complete mesocolic excision vs non‐complete mesocolic excision in patients with colon cancer: a systemic review and meta‐analysis. Colorectal Disease. 19(11). 962–972. 74 indexed citations
14.
Ren, Yongcheng, Ming Zhang, Xinping Luo, et al.. (2017). Secular trend of the leading causes of death in China from 2003 to 2013. African Health Sciences. 17(2). 532–532. 5 indexed citations
15.
Li, Jing, et al.. (2016). Synergistic effects of sorafenib in combination with gemcitabine or pemetrexed in lung cancer cell lines with K-ras mutations. Współczesna Onkologia. 1(1). 33–38. 13 indexed citations
16.
Wang, Lirong, Anthony J. Santella, Ruizhe Huang, et al.. (2015). Knowledge of HIV and Willingness to Conduct Oral Rapid HIV Testing among Dentists in Xi’an China. PLoS ONE. 10(3). e0119274–e0119274. 14 indexed citations
18.
Li, Changbin, Shu Wang, Yaxiang Song, et al.. (2015). PSTK is a novel gene associated with early lung injury in Paraquat Poisoning. Life Sciences. 123. 9–17. 6 indexed citations
19.
Wang, Shu, Fuzhong Tong, Jiaqing Zhang, et al.. (2009). Response to neoadjuvant therapy and disease free survival in patients with triple-negative breast cancer.. PubMed. 36(2). 255–8. 27 indexed citations
20.
Wang, Shu. (2003). Key technology of fingerprint spectrum analysis on Chinese materia medica. Zhongcaoyao. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026